Rubius Therapeutics, Inc.
RUBYDelisted Mar 28, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001709401
Rubius Therapeutics, Inc. was delisted on Mar 28, 2023; its insiders filed their last Form 4 on Feb 27, 2023; 42 institutions reported holding it in 13F filings for Q4 2022, worth $11.2M in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in Rubius Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 117
- +9 vs. Q4 2021
- Shares held
- 89.6M
- +423.7K (+0.5%) vs. Q4 2021
- Total value
- $493.9M
- −$369.7M (−42.8%) vs. Q4 2021
- New holders
- 21
- 39 more added
- Sold out
- 12
- 33 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RUBY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 7 | $61.3K |
| Q4 2022 | 42 | $11.2M |
| Q3 2022 | 62 | $29.7M |
| Q2 2022 | 73 | $66.6M |
| Q1 2022 | 117 | $493.9M |
| Q4 2021 | 108 | $863.6M |
| Q3 2021 | 105 | $1.55B |
| Q2 2021 | 108 | $2.09B |
| Q1 2021 | 105 | $2.23B |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Rubius Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Great West Life Assurance Co | 2,259 | $13.0K | 0.00% | 00.0% | Unchanged |
| Byrne Asset Management LLC | 1,010 | $6.00K | 0.00% | −2,800−73.5% | Reduced |
| Signaturefd, LLC | 1,119 | $6.00K | 0.00% | +897+404.1% | Added |
| Tower Research Capital LLC (TRC) | 747 | $4.00K | 0.00% | −8,670−92.1% | Reduced |
| Whittier Trust Co | 715 | $4.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 522 | $3.00K | 0.00% | −105,682−99.5% | Reduced |
| Aquatic Capital Management LLC | 600 | $3.00K | 0.00% | +400+200.0% | Added |
| US Bancorp | 336 | $2.00K | 0.00% | −950−73.9% | Reduced |
| Daiwa Securities Group Inc. | 307 | $2.00K | 0.00% | 00.0% | Unchanged |
| American Portfolios Advisors | 325 | $1.79K | 0.00% | 00.0% | Unchanged |
| Mascoma Wealth Management LLC | 250 | $1.00K | 0.00% | 00.0% | Unchanged |
| Captrust Financial Advisors | 150 | $1.00K | 0.00% | +150 | New |
| CWM, LLC | 112 | $1.00K | 0.00% | +112 | New |
| Quadrant Capital Group LLC | 162 | $1.00K | 0.00% | +162 | New |
| Kelly Financial Services LLC | 100 | $551 | 0.00% | +100 | New |
| Lindbrook Capital, LLC | 87 | $0 | 0.00% | −99−53.2% | Reduced |
| Ellevest, Inc. | 24 | $0 | 0.00% | +24 | New |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −119,669−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −43,117−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −30,314−100.0% | Sold out |
| HITE Hedge Asset Management LLC | 0 | $0 | 0.00% | −24,911−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −17,455−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −17,211−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −12,771−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −4,803−100.0% | Sold out |
| High Net Worth Advisory Group LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −332−100.0% | Sold out |
| Retirement Planning Co of New England, Inc. | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Covestor Ltd | 0 | $0 | 0.00% | −23−100.0% | Sold out |